Orange County Research Center   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Tustin CA United States (1985)

Organization Overview

First Clinical Trial
2008
NCT00635232
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Orange County Research Center | Orange County Research Center (OCRC)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Essential Hypertension (Phase 2)

Heart Failure (Phase 2)

Hypersensitivity (Phase 1)

Hypersensitivity, Immediate (Phase 1)

Hypertension (Phase 2)

Neuralgia (Phase 1)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Rhinitis, Allergic, Seasonal (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 16
  • # of Trial APIs: 15